California Public Employees Retirement System cut its stake in shares of Vascular Solutions Inc. (NASDAQ:VASC) by 1.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 50,900 shares of the medical device company’s stock after selling 1,000 shares during the period. California Public Employees Retirement System owned approximately 0.29% of Vascular Solutions worth $2,120,000 at the end of the most recent reporting period.
A number of other large investors have also recently modified their holdings of VASC. Falcon Point Capital LLC increased its stake in shares of Vascular Solutions by 12.4% in the second quarter. Falcon Point Capital LLC now owns 42,579 shares of the medical device company’s stock valued at $1,774,000 after buying an additional 4,710 shares during the last quarter. Capstone Asset Management Co. increased its stake in shares of Vascular Solutions by 18.3% in the second quarter. Capstone Asset Management Co. now owns 9,580 shares of the medical device company’s stock valued at $399,000 after buying an additional 1,480 shares in the last quarter. Emerald Acquisition Ltd. bought a new stake in shares of Vascular Solutions during the second quarter valued at about $4,836,000. Prudential Financial Inc. increased its stake in shares of Vascular Solutions by 3.7% in the first quarter. Prudential Financial Inc. now owns 42,347 shares of the medical device company’s stock valued at $1,378,000 after buying an additional 1,500 shares in the last quarter. Finally, Menta Capital LLC bought a new stake in shares of Vascular Solutions during the first quarter valued at about $320,000. 82.08% of the stock is owned by hedge funds and other institutional investors.
Shares of Vascular Solutions Inc. (NASDAQ:VASC) traded up 0.08% on Wednesday, reaching $47.57. 34,525 shares of the company traded hands. Vascular Solutions Inc. has a one year low of $24.34 and a one year high of $50.72. The firm has a 50-day moving average price of $48.46 and a 200 day moving average price of $41.37. The company has a market capitalization of $832.05 million, a PE ratio of 88.09 and a beta of 0.54.
Vascular Solutions (NASDAQ:VASC) last issued its quarterly earnings results on Monday, July 25th. The medical device company reported $0.33 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.30 by $0.03. The firm had revenue of $41.20 million for the quarter, compared to the consensus estimate of $41.40 million. Vascular Solutions had a net margin of 6.22% and a return on equity of 16.32%. The company’s revenue for the quarter was up 9.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.29 EPS. Equities analysts forecast that Vascular Solutions Inc. will post $1.24 EPS for the current fiscal year.
VASC has been the subject of several research reports. Zacks Investment Research downgraded shares of Vascular Solutions from a “buy” rating to a “hold” rating in a research report on Wednesday, September 28th. Canaccord Genuity reissued a “buy” rating on shares of Vascular Solutions in a research report on Wednesday, August 10th. TheStreet raised shares of Vascular Solutions from a “hold” rating to a “buy” rating in a research report on Monday, July 25th. Piper Jaffray Cos. increased their price objective on shares of Vascular Solutions from $45.00 to $49.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 26th. Finally, Sidoti downgraded shares of Vascular Solutions from a “buy” rating to a “neutral” rating and set a $47.00 price objective for the company. in a research report on Tuesday, July 12th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $47.38.
In other news, VP William Rutstein sold 10,011 shares of Vascular Solutions stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of $46.26, for a total value of $463,108.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Howard Root sold 40,000 shares of Vascular Solutions stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of $45.11, for a total transaction of $1,804,400.00. Following the completion of the sale, the chief executive officer now owns 347,840 shares of the company’s stock, valued at approximately $15,691,062.40. The disclosure for this sale can be found here. 6.90% of the stock is currently owned by insiders.
Vascular Solutions Company Profile
Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.
Want to see what other hedge funds are holding VASC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vascular Solutions Inc. (NASDAQ:VASC).
Receive News & Ratings for Vascular Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.